Inhibition of NADPH oxidase 4 induces apoptosis in malignant mesothelioma: Role of reactive oxygen species.

Malignant pleural mesothelioma (MPM) is an aggressive tumor that is characterized by dysregulated growth and resistance to apoptosis. Reactive oxygen species (ROS)-generating NADPH oxidase (Nox) family enzymes have been suggested to be involved in neoplastic proliferation. Both the antioxidant N-acetylcysteine (NAC) and the inhibitor of flavoprotein-dependent oxidase, diphenylene iodonium (DPI), inhibited the cell viability of MPM cells in a dose-dependent manner. To examine whether Nox-mediated ROS generation confers antiapoptotic activity and thus a growth advantage to MPM cells, we analyzed the mRNA expression of Nox family members using quantitative RT-PCR in 7 MPM cell lines and a normal mesothelial cell line. Nox4 mRNA was expressed in all of the examined MPM cell lines, whereas little or no Nox2, Nox3 and Nox5 mRNA expression was detected. In 2 MPM cell lines, Nox4 mRNA expression was significantly higher than that in a normal mesothelial cell line. siRNAs targeting Nox4 suppressed ROS generation and cell viability in the MPM cell lines. In addition, DPI treatment and knockdown of Nox4 attenuated phosphorylation of AKT and ERK. Taken together, our results indicate that Nox4-mediated ROS, at least in part, transmit cell survival signals and their depletion leads to apoptosis, thus highlighting the Nox4-ROS-AKT signaling pathway as a potential therapeutic target for MPM treatment.

[1]  M. Meyerson,et al.  Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma. , 2015, Cancer research.

[2]  S. Armato,et al.  Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  H. Rehrauer,et al.  Role of Hedgehog Signaling in Malignant Pleural Mesothelioma , 2012, Clinical Cancer Research.

[4]  P. Rascoe,et al.  Molecular pathogenesis of malignant mesothelioma , 2012, Expert Reviews in Molecular Medicine.

[5]  J. Doroshow,et al.  Antiproliferative mechanisms of action of the flavin dehydrogenase inhibitors diphenylene iodonium and di-2-thienyliodonium based on molecular profiling of the NCI-60 human tumor cell panel. , 2012, Biochemical pharmacology.

[6]  Hidemi Ito,et al.  TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth , 2012, The Journal of experimental medicine.

[7]  A. Gazdar,et al.  Malignant mesothelioma: Facts, Myths, and Hypotheses , 2012, Journal of cellular physiology.

[8]  M. Carbone,et al.  Molecular Pathways: Targeting Mechanisms of Asbestos and Erionite Carcinogenesis in Mesothelioma , 2011, Clinical Cancer Research.

[9]  N. Cox,et al.  Germline BAP1 mutations predispose to malignant mesothelioma , 2011, Nature Genetics.

[10]  J. Doroshow,et al.  Up-regulation and Sustained Activation of Stat1 Are Essential for Interferon-γ (IFN-γ)-induced Dual Oxidase 2 (Duox2) and Dual Oxidase A2 (DuoxA2) Expression in Human Pancreatic Cancer Cell Lines* , 2011, The Journal of Biological Chemistry.

[11]  Nicholas Campbell1,et al.  Update on Malignant Pleural Mesothelioma , 2011, Seminars in respiratory and critical care medicine.

[12]  Y. Kondo,et al.  LATS2 is a tumor suppressor gene of malignant mesothelioma. , 2011, Cancer research.

[13]  Keshav K. Singh,et al.  NADPH oxidase 4 is an oncoprotein localized to mitochondria , 2010, Cancer biology & therapy.

[14]  J. Keaney,et al.  Downstream targets and intracellular compartmentalization in Nox signaling. , 2009, Antioxidants & redox signaling.

[15]  Ignacio Wistuba,et al.  Malignant Pleural Mesothelioma , 2017 .

[16]  T. Saida,et al.  NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression. , 2009, Cancer research.

[17]  R. Stahel,et al.  Improving the outcome in malignant pleural mesothelioma: nonaggressive or aggressive approach? , 2009, Current opinion in oncology.

[18]  Y. Kondo,et al.  Activation of the PI3K-AKT pathway in human malignant mesothelioma cells. , 2009, Molecular medicine reports.

[19]  J. Doroshow,et al.  Expression of NADPH oxidase homologues and accessory genes in human cancer cell lines, tumours and adjacent normal tissues , 2009, Free radical research.

[20]  K. Akashi,et al.  Enhanced expression of NADPH oxidase Nox4 in human gliomas and its roles in cell proliferation and survival , 2008, International journal of cancer.

[21]  M. Ushio-Fukai,et al.  Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. , 2008, Cancer letters.

[22]  M. Zhang,et al.  Redox signalling involving NADPH oxidase-derived reactive oxygen species. , 2006, Biochemical Society transactions.

[23]  S. Furuta,et al.  Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells , 2006, Oncogene.

[24]  D. Schrump,et al.  Suppression of pro-metastasis phenotypes expression in malignant pleural mesothelioma by the PI3K inhibitor LY294002 or the MEK inhibitor UO126. , 2006, Anticancer research.

[25]  B. Robinson,et al.  Advances in malignant mesothelioma. , 2005, The New England journal of medicine.

[26]  P. Storz Reactive oxygen species in tumor progression. , 2005, Frontiers in bioscience : a journal and virtual library.

[27]  C. Thoburn,et al.  Association of Foxp3 regulatory gene expression with graft-versus-host disease. , 2004, Blood.

[28]  S. Pandol,et al.  Reactive Oxygen Species Produced by NAD(P)H Oxidase Inhibit Apoptosis in Pancreatic Cancer Cells* , 2004, Journal of Biological Chemistry.

[29]  K. O'Byrne,et al.  The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma. , 2004, The Annals of thoracic surgery.

[30]  J. Lambeth NOX enzymes and the biology of reactive oxygen , 2004, Nature Reviews Immunology.

[31]  Su-Jae Lee,et al.  Oxidative stress-induced apoptosis is mediated by ERK1/2 phosphorylation. , 2003, Experimental cell research.

[32]  M. Geiszt,et al.  Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  Claude Denham,et al.  Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  J. Hoidal,et al.  An NAD(P)H oxidase regulates growth and transcription in melanoma cells. , 2002, American journal of physiology. Cell physiology.

[35]  Erwin G. Van Meir,et al.  Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. , 2001, Gene.

[36]  F Levi,et al.  The European mesothelioma epidemic , 1999, British Journal of Cancer.

[37]  C. Nathan,et al.  Production of large amounts of hydrogen peroxide by human tumor cells. , 1991, Cancer research.

[38]  Ken Takahashi,et al.  Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model. , 2006, American journal of industrial medicine.

[39]  M. Geiszt,et al.  Dual oxidases , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.